Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
12 /100
LOW RISK
Score updated Oct 13, 2026

CRNX — Crinetics Pharmaceuticals, Inc. Dilution Risk Tracker

Track CRNX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CRNX — Get alerts when the score changes →

As of October 13, 2026, Crinetics Pharmaceuticals, Inc. (CRNX) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Crinetics Pharmaceuticals, Inc. has a market capitalization of $9.01B, 106.07M shares outstanding, 245 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CRNX.
🔔 Track CRNX — Get forecast alerts →

Market Data

Market Cap$9.01B
Shares Outstanding106.07M
Float95.58M
Cash$1.21B
Debt$47.85M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore12/100DilutionWatch score record
Shares Outstanding106.07MVerified float table or market cache
Public Float95.58MVerified float table or market cache
Market Cap$9.01BMarket data cache
Cash Runway47.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.3% shares (2026Q1 vs prior)
245 institutional holders · 136.93M shares
#1 FMR LLC 15.76M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 9.35M shares
#3 JANUS HENDERSON GROUP PLC 9.04M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.85M
Days to Cover2.4
% of Float7.2%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-26
xbrl XBRL CONVERTIBLE 2021-03-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CRNX Dilution Snapshot

Crinetics Pharmaceuticals, Inc. (CRNX) has a DilutionScore of 12/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CRNX's DilutionScore has held steady at 12/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202612/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CRNX shares outstanding have increased 2.9% from 102.51M (Mar 2026) to 105.44M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 2026105.44M95.58M▼ 1.45%
May 12, 2026105.44M96.99M▲ 0.06%
May 11, 2026105.44M96.93M▲ 0.70%
Apr 07, 2026104.71M96.25M▼ 0.08%
Mar 05, 2026102.51M96.32M▲ 0.19%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CRNX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CRNX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CRNX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CRNX
CRNX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.